ScholarIQanswers from OpenAlex

Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia

PaperCitations, authors & open-access status

Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia have?

ScholarIQcitation count

Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia has 59 citations in the OpenAlex counts ScholarIQ stores.

When was Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia published?

ScholarIQyear

Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia has 2012 year in the ScholarIQ index.

What is the open-access status of Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia?

ScholarIQoa status

Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia has closed oa status in the ScholarIQ index.

What is the DOI of Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia?

ScholarIQdoi

The DOI for Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia is on the source record.

What is the PMID of Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia?

ScholarIQpmid

The PMID for Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia is on the source record.

What is the OpenAlex record for Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia?

ScholarIQopenalex

The OpenAlex for Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial